Drugs Made In America Acquisition Corp.
DMAA
$10.33
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.67% | -95.58% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | -18.50% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 1,242.86% | -36.36% | |||
|
|
|||||
| Total Current Assets | 1,242.86% | -36.36% | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 55,938.73% | 208,002.65% | |||
| Total Assets | 55,669.16% | 122,979.91% | |||
|
|
|||||
| Total Accounts Payable | -- | -- | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 387.34% | 17,011.11% | |||
| Total Other Current Liabilities | 387.34% | 17,011.11% | |||
| Total Current Liabilities | -22.74% | 42.84% | |||
|
|
|||||
| Total Current Liabilities | -22.74% | 42.84% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 41,348.53% | 114,761.33% | |||
|
|
|||||
| Common Stock & APIC | -96.86% | -96.86% | |||
| Retained Earnings | -3,261.98% | -11,661.20% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -4,344.15% | -35,838.19% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -4,344.15% | -35,838.19% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -4,344.15% | -35,838.19% | |||
|
|
|||||